Eyenovia announces accumulation of over 1M HYPE tokens

Eyenovia (EYEN) announced the closing of its previously announced $50 million private placement with accredited investors. The PIPE Financing enabled the Company to acquire 1,040,584.5 HYPE at an average price of approximately $34 per token. As part of the strategy, the Company also intends to initiate its own network validator alongside an ecosystem partner, which will support the liveness of the Hyperliquid blockchain and lay the foundation for accessing HYPE staking yield. Chardan acted as the sole placement agent in connection with the transaction. Pending Board approval in the coming days, Eyenovia is expected to change its name and ticker to “Hyperion DeFi” and “HYPD,” respectively. Development of the Optejet UFD continues to progress according to the Company’s projected timelines, with verification and validation activities expected to commence next month. Eyenovia remains on track to register the device with the FDA in September of this year. The Company has initiated dialogue with several potential partners for licensure of the platform, initially focused on applications in OTC lens rewetting and artificial tears.